Ensho Therapeutics, Inc.
through Oct 15, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Feb 9, 2026 · D | Oct 15, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $20,000,000 | $15,604,179 | $-4,395,821 |
| Reported amount sold | $0 | $7,281,948 | $7,281,948 |
| Reported investor count | — | 7 | — |
| Reported minimum investment | $1 | $1 | $0 |
Earlier SEC source: 0002032849-26-000001 · Later SEC source: 0002032849-26-000002
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $15,604,179
- Reported amount sold
- $7,281,948
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20262 filings
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (3)
-
0002032849-26-000002D · Oct 15, 2026 · BiotechnologyOffering: $15,604,179Sold: $7,281,948
-
0002032849-26-000001D · Feb 9, 2026 · BiotechnologyOffering: $20,000,000Sold: $0
-
0002032849-25-000003D · Sep 12, 2025 · BiotechnologyOffering: $22,500,000Sold: $22,500,000